Patents by Inventor Hermann Haller

Hermann Haller has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20100247450
    Abstract: The present invention relates to the use of erythropoietin for stimulating the physiological mobilization, proliferation and differentiation of endothelial progenitor cells, for stimulating vasculogenesis, for the therapy of diseases associated with a dysfunction of endothelial progenitor cells and for producing pharmaceutical compositions for the treatment of such diseases, and pharmaceutical compositions which comprise erythropoietin and other suitable active ingredients for stimulating endothelial progenitor cells.
    Type: Application
    Filed: April 13, 2010
    Publication date: September 30, 2010
    Applicant: EPOPLUS GMBH & CO. KG
    Inventors: Ferdinand Hermann Bahlmann, Hermann Haller
  • Publication number: 20100247452
    Abstract: The present invention relates to the use of erythropoietin for stimulating the physiological mobilization, proliferation and differentiation of endothelial progenitor cells, for stimulating vasculogenesis, for the therapy of diseases associated with a dysfunction of endothelial progenitor cells and for producing pharmaceutical compositions for the treatment of such diseases, and pharmaceutical compositions which comprise erythropoietin and other suitable active ingredients for stimulating endothelial progenitor cells.
    Type: Application
    Filed: April 13, 2010
    Publication date: September 30, 2010
    Applicant: EPOPLUS GMBH & CO. KG
    Inventors: Ferdinand Hermann Bahlmann, Hermann Haller
  • Publication number: 20100247451
    Abstract: The present invention relates to the use of erythropoietin for stimulating the physiological mobilization, proliferation and differentiation of endothelial progenitor cells, for stimulating vasculogenesis, for the therapy of diseases associated with a dysfunction of endothelial progenitor cells and for producing pharmaceutical compositions for the treatment of such diseases, and pharmaceutical compositions which comprise erythropoietin and other suitable active ingredients for stimulating endothelial progenitor cells.
    Type: Application
    Filed: April 13, 2010
    Publication date: September 30, 2010
    Applicant: EPOPLUS GMBH & CO. KG
    Inventors: Ferdinand Hermann Bahlmann, Hermann Haller
  • Patent number: 7745387
    Abstract: The present invention relates to the use of erythropoietin for stimulating the physiological mobilization, proliferation and differentiation of endothelial progenitor cells, for stimulating vasculogenesis, for the therapy of diseases associated with a dysfunction of endothelial progenitor cells and for producing pharmaceutical compositions for the treatment of such diseases, and pharmaceutical compositions which comprise erythropoietin and other suitable active ingredients for stimulating endothelial progenitor cells.
    Type: Grant
    Filed: July 25, 2003
    Date of Patent: June 29, 2010
    Assignee: Epoplus GmbH & Co. KG
    Inventors: Ferdinand Hermann Bahlmann, Hermann Haller
  • Publication number: 20090191194
    Abstract: The invention relates to the use of agents impeding the expression and/or activity of protein kinase C-alpha (PKC-?), especially for treatment of patients with diabetes and complications such as diabetic nephropathy, retinopathy or neuropathy.
    Type: Application
    Filed: December 1, 2008
    Publication date: July 30, 2009
    Applicant: Phenos GmbH
    Inventors: Jan MENNE, Hermann Haller
  • Patent number: 7258775
    Abstract: The invention relates to a method for the qualitative and/or quantitative analysis of a protein and/or peptide pattern of a liquid sample that is derived from the human or animal body. The proteins and peptides of the liquid sample are separated by capillary electrophoresis, then directly ionized and transferred for analysis online via an interface to a mass spectrometer coupled thereto.
    Type: Grant
    Filed: May 4, 2001
    Date of Patent: August 21, 2007
    Assignee: mosaiques diagnostics and therapeutics AG
    Inventors: Harald Mischak, Hermann Haller
  • Publication number: 20070161552
    Abstract: The present invention relates to the use of low-dosage erythropoietin for stimulation of physiological mobilization, proliferation and differentiation of endothelial progenitor cells, for stimulation of vasculogenesis, for therapy of diseases related to a dysfunction of endothelial progenitor cells, and for production of pharmaceutical compositions for treatment of such diseases as well as pharmaceutical compositions that include erythropoietin and other suitable active ingredients for stimulation of endothelial progenitor cells.
    Type: Application
    Filed: January 22, 2005
    Publication date: July 12, 2007
    Inventors: Ferdinand Bahlmann, Hermann Haller
  • Publication number: 20050272634
    Abstract: The present invention relates to the use of erythropoietin for stimulating the physiological mobilization, proliferation and differentiation of endothelial progenitor cells, for stimulating vasculogenesis, for the therapy of diseases associated with a dysfunction of endothelial progenitor cells and for producing pharmaceutical compositions for the treatment of such diseases, and pharmaceutical compositions which comprise erythropoietin and other suitable active ingredients for stimulating endothelial progenitor cells.
    Type: Application
    Filed: July 25, 2003
    Publication date: December 8, 2005
    Inventors: Ferdinand Bahlmann, Hermann Haller
  • Publication number: 20050250719
    Abstract: The invention relates to the use of agents impeding the expression and/or activity of protein kinase C-alpha (PKC-?), especially for treatment of patients with diabetes and complications such as diabetic nephropathy, retinopathy or neuropathy.
    Type: Application
    Filed: September 23, 2003
    Publication date: November 10, 2005
    Applicant: Phenos GmbH
    Inventors: Jan Menne, Hermann Haller
  • Publication number: 20030132114
    Abstract: The invention relates to a method for the qualitative and/or quantitative analysis of a protein and/or peptide pattern of a liquid sample that is derived from the human or animal body. The proteins and peptides of the liquid sample are separated by capillary electrophoresis, then directly ionized and transferred for analysis online via an interface to a mass spectrometer coupled thereto.
    Type: Application
    Filed: November 1, 2002
    Publication date: July 17, 2003
    Inventors: Harald Mischak, Hermann Haller